215 related articles for article (PubMed ID: 28498455)
1. Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.
Ujiie H; Kato T; Lee D; Hu HP; Fujino K; Kaji M; Kaga K; Matsui Y; Yasufuku K
Int J Oncol; 2017 Jun; 50(6):2154-2170. PubMed ID: 28498455
[TBL] [Abstract][Full Text] [Related]
2. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
[TBL] [Abstract][Full Text] [Related]
3. MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray.
Sang M; Gu L; Yin D; Liu F; Lian Y; Zhang X; Liu S; Huang W; Wu Y; Shan B
J Clin Pathol; 2017 Jun; 70(6):533-540. PubMed ID: 27864450
[TBL] [Abstract][Full Text] [Related]
4. The role of MAGEA2 in head and neck cancer.
Glazer CA; Smith IM; Bhan S; Sun W; Chang SS; Pattani KM; Westra W; Khan Z; Califano JA
Arch Otolaryngol Head Neck Surg; 2011 Mar; 137(3):286-93. PubMed ID: 21422315
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of KIF23 predicts clinical outcome in primary lung cancer patients.
Kato T; Wada H; Patel P; Hu HP; Lee D; Ujiie H; Hirohashi K; Nakajima T; Sato M; Kaji M; Kaga K; Matsui Y; Tsao MS; Yasufuku K
Lung Cancer; 2016 Feb; 92():53-61. PubMed ID: 26775597
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
7. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
[TBL] [Abstract][Full Text] [Related]
8. Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients.
Meng Q; Luo G; Liu B; Sun Y; Yan Z
Neoplasma; 2018; 65(4):604-609. PubMed ID: 30064232
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
[TBL] [Abstract][Full Text] [Related]
10. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of mutant p53 protein expression in lung adenocarcinoma].
Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):23-8. PubMed ID: 25603869
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
Zhang L; Zhou XF; Pan GF; Zhao JP
Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.
Cha YJ; Kim HR; Lee CY; Cho BC; Shim HS
Lung Cancer; 2016 Jul; 97():73-80. PubMed ID: 27237031
[TBL] [Abstract][Full Text] [Related]
14. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism].
Pan GF; Zhou XF; Zhao JP
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204
[No Abstract] [Full Text] [Related]
16. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
[TBL] [Abstract][Full Text] [Related]
17. The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM.
Zeng L; Kang C; Di C; Fee BE; Rivas M; Lin J; Adamson DC
Int J Oncol; 2014 Apr; 44(4):1243-51. PubMed ID: 24481586
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
19. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents.
Monte M; Simonatto M; Peche LY; Bublik DR; Gobessi S; Pierotti MA; Rodolfo M; Schneider C
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11160-5. PubMed ID: 16847267
[TBL] [Abstract][Full Text] [Related]
20. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J
Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
